In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
CS-834 is a novel oral carbapenem antibiotic. This compound is an ester-type prodrug of the active metabolite R-95867. The antibacterial activity of R-95867 was tested against 1,323 clinical isolates of 35 species and was compared with those of oral cephems, i.e., cefteram, cefpodoxime, cefdinir, an...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1997
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164185/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9420035/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.12.2652 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
